Merck and Ridgeback Biotherapeutics says COVID antiviral reduced risk of hospitalization or death in …

merck and ridgeback biotherapeutics says covid antiviral reduced risk of hospitalization or death in at risk adults

Sumary of Merck and Ridgeback Biotherapeutics says COVID antiviral reduced risk of hospitalization or death in at risk adults:

  • Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.
  • It operates through the following segments: Pharmaceutical, Animal Health, and Other.
  • The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close